AB
ARPON BISWAS
Jubilant Biosys Limited, Central Drug Research Institute, National Institute of Pharmaceutical Education and Research Guwahati
Employment
-
Jubilant Biosys Limited Research Scientist2025 - Present
-
Central Drug Research Institute Project Associate-II2024 - 2025
-
Central Drug Research Institute ICMR Senior Research Fellow2021 - 2024
-
National Institute of Pharmaceutical Education and Research Guwahati PROJECT ASSISTANT2020 - 2021
-
Central Drug Research Institute PROJECT ASSISTANT2018 - 2019
-
Ozone Pharmaceuticals Ltd ASSISTANT CHEMIST2013 - 2015
Education
-
Central Drug Research Institute Ph.D2021 - 2025
Projects & Funding
Projects & funding information is unavailable.
Publications (34)
- Targeted Pharmacokinetics and LC–MS/MS Analysis of Novel Anti‐Dyslipidemic Phytochemical Biomarkers From Polyalthia longifolia Enriched Fraction (4655‐EF) Save
- Ointment for Topical Ocular Delivery of Voriconazole: Formulation Development, In‐Vitro Characterization & In‐Vivo Pharmacokinetic Assessment Save
- Corneal Targeted Mucoadhesive Emulsion for Prolonged Delivery of Voriconazole: Formulation Evaluation and Pharmacokinetic Assessment Save
- Targeting EZH2 and EGFR Therapeutic Vulnerabilities of TNBC with a Single Chemical Entity Confers Preclinical Treatment Advantage Save
- Design, Synthesis, and Biological Evaluation of Isoxazole-Dihydropyrimidinone Hybrids as Potential Modulators of Adipogenesis and Dyslipidemia Save
- Codetermination of antimicrobial agents in rabbit tear fluid using LC–MS/MS assay: Insights into ocular pharmacokinetic study Save
- Simultaneous determination of amphotericin B, tobramycin and vancomycin in rabbit ocular biofluids and tissues by LC-MS/MS: An antimicrobial therapy for keratitis and its PK-PD application Save
- Concurrent determination of anti-microbial and anti-inflammatory drugs in lachrymal fluid and tissue by LC-MS/MS: A potential treatment for microbial keratitis and its PK-PD evaluation Save
- Recent Insights into the Etiopathogenesis of Diabetic Retinopathy and Its Management Save
- Pirfenidone: A Promising Drug in Ocular Therapeutics Save